{"title":"The Relationship between Phenotypic Classification and Inflammatory Parameters in Patients Hospitalized with Acute Heart Failure.","authors":"Armağan Kaya, Mustafa Gökçe","doi":"10.18087/cardio.2025.4.n2760","DOIUrl":null,"url":null,"abstract":"<p><p>Aim To evaluate the effects of inflammatory parameters on mortality and prognosis in patients who were hospitalized with acute heart failure (AHF) and phenotypically classified.Material and methods Between December 2020 and August 2021, 240 patients, who were newly diagnosed with acute heart failure (AHF) or those with heart failure and who developed decompensation, were prospectively included in the study. The patients composed four equal groups of 60 patients each according to the phenotypical class of AHF: warm-wet, warm-dry, cold-wet, and cold-dry. Acute phase reactants, namely C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and plasma albumin, were examined at hospitalization, discharge, and 30±7 days after discharge. The reactants were compared between the groups in terms of mortality and prognosis.Results Univariate analyses showed that, at the time of initial hospitalization, a one-unit increase in albumin decreased the mortality risk 0.794‑fold, while a one-unit increase in CRP increased the mortality risk 1.013‑fold and a one-unit increase in ESR increased the mortality risk 1.026‑fold (p<0.001, p=0.003, and p=0.002, respectively). At discharge, a one-unit increase in albumin decreased the mortality risk 0.85‑fold (p=0.043). However, multivariate analyses showed that, at the time of initial hospitalization, a one-unit increase in albumin decreased the mortality risk 0.803‑fold, while a one-unit increase in the ESR value increased the mortality risk 1.021‑fold (p<0.001 and p=0.049, respectively). Although a statistically significant difference was observed between the warm-dry group and the other groups in terms of in-hospital mortality distributions (p=0.032), there was no statistically significant difference between the groups in terms of out-of-hospital mortality (p>0.050).Conclusion In AHF patients, low albumin values at initial hospitalization and discharge, high CRP and ESR values at initial hospitalization predict increased mortality.</p>","PeriodicalId":54750,"journal":{"name":"Kardiologiya","volume":"65 4","pages":"16-22"},"PeriodicalIF":0.5000,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kardiologiya","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18087/cardio.2025.4.n2760","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Aim To evaluate the effects of inflammatory parameters on mortality and prognosis in patients who were hospitalized with acute heart failure (AHF) and phenotypically classified.Material and methods Between December 2020 and August 2021, 240 patients, who were newly diagnosed with acute heart failure (AHF) or those with heart failure and who developed decompensation, were prospectively included in the study. The patients composed four equal groups of 60 patients each according to the phenotypical class of AHF: warm-wet, warm-dry, cold-wet, and cold-dry. Acute phase reactants, namely C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and plasma albumin, were examined at hospitalization, discharge, and 30±7 days after discharge. The reactants were compared between the groups in terms of mortality and prognosis.Results Univariate analyses showed that, at the time of initial hospitalization, a one-unit increase in albumin decreased the mortality risk 0.794‑fold, while a one-unit increase in CRP increased the mortality risk 1.013‑fold and a one-unit increase in ESR increased the mortality risk 1.026‑fold (p<0.001, p=0.003, and p=0.002, respectively). At discharge, a one-unit increase in albumin decreased the mortality risk 0.85‑fold (p=0.043). However, multivariate analyses showed that, at the time of initial hospitalization, a one-unit increase in albumin decreased the mortality risk 0.803‑fold, while a one-unit increase in the ESR value increased the mortality risk 1.021‑fold (p<0.001 and p=0.049, respectively). Although a statistically significant difference was observed between the warm-dry group and the other groups in terms of in-hospital mortality distributions (p=0.032), there was no statistically significant difference between the groups in terms of out-of-hospital mortality (p>0.050).Conclusion In AHF patients, low albumin values at initial hospitalization and discharge, high CRP and ESR values at initial hospitalization predict increased mortality.
期刊介绍:
“Kardiologiya” (Cardiology) is a monthly scientific, peer-reviewed journal committed to both basic cardiovascular medicine and practical aspects of cardiology.
As the leader in its field, “Kardiologiya” provides original coverage of recent progress in cardiovascular medicine. We publish state-of-the-art articles integrating clinical and research activities in the fields of basic cardiovascular science and clinical cardiology, with a focus on emerging issues in cardiovascular disease. Our target audience spans a diversity of health care professionals and medical researchers working in cardiovascular medicine and related fields.
The principal language of the Journal is Russian, an additional language – English (title, authors’ information, abstract, keywords).
“Kardiologiya” is a peer-reviewed scientific journal. All articles are reviewed by scientists, who gained high international prestige in cardiovascular science and clinical cardiology. The Journal is currently cited and indexed in major Abstracting & Indexing databases: Web of Science, Medline and Scopus.
The Journal''s primary objectives
Contribute to raising the professional level of medical researchers, physicians and academic teachers.
Present the results of current research and clinical observations, explore the effectiveness of drug and non-drug treatments of heart disease, inform about new diagnostic techniques; discuss current trends and new advancements in clinical cardiology, contribute to continuing medical education, inform readers about results of Russian and international scientific forums;
Further improve the general quality of reviewing and editing of manuscripts submitted for publication;
Provide the widest possible dissemination of the published articles, among the global scientific community;
Extend distribution and indexing of scientific publications in major Abstracting & Indexing databases.